Abstract
India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to
2012
Summary
This report is an essential source for in-depth information and data relating
to the India In vitro diagnostic dvices market. It also offers detailed and
comprehensive coverage of market revenue, distribution and company share
information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the In vitro diagnostic dvices
in India
Scope
・ The report provides in vitro diagnostics information broken down into
detailed categories and segments in India.
・ Total revenues, end
users
・ Market shares of all the key competitors.
・ Key pipeline
products that are set to shape the market, broken down by sector.
・
Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis.
・ Healthcare
structure, regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the in vitro diagnostics devices market in
India.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of
markets covered in the report 14
3.1 In Vitro Diagnostics 14
3.2
Clinical Biochemistry Test Reagents 14
3.3 Immunochemistry Test Reagents
14
3.3.1 Disease Specific Markers 14
3.3.2 Disease Specific Test
Reagents 14
3.3.3 Drug Related Testing Reagents 15
3.3.4 Hormone
Related Testing Reagents 15
3.3.5 Immunohistochemistry 15
3.4
Hematology & Histopathology Test Reagents 16
3.4.1 Hematology Test
Reagents 16
3.4.2 Histopathology Reagents 16
3.5 Microbiology Test
Reagents 17
3.5.1 Bacteriology Test Reagents 17
3.6 Infectious
Immunology Test Reagents 17
3.6.1 Virology Test Reagents 17
3.6.2
Parasitology Tests Reagents 17
3.7 Instruments 17
3.8 Rapid Tests
17
3.8.1 Infectious Immunology Rapid Tests 18
3.8.2 Microbiology Rapid
Tests 18
3.8.3 Immunochemistry Rapid Tests 18
3.8.4 Clinical Chemistry
Rapid Tests 18
4 Healthcare Sector Review 19
4.1 Healthcare
Expenditure 19
4.2 Healthcare Infrastructure 21
4.2.1 Healthcare
Infrastructure (2007) 22
4.3 Healthcare Policy 23
5 Regulation System
24
5.1 Medical Equipment Approval 24
5.2 Central Drugs Authority of
India (CDAI) 25
5.3 Medical Device Regulatory Authority of India (MDRAI)
25
5.4 Classification of Medical Devices 25
5.4.1 Registration Period
26
6 Pricing and Reimbursement 27
6.1 Pricing and Reimbursement 27
7 Distribution Structure 28
7.1 Distribution Structure 28
8 In Vitro
Diagnostics in India 29
8.1 In Vitro Diagnostics Overall Revenues by
Category (2000-2012) 29
9 Instruments in India 32
9.1 Instruments
Revenues (2000-2012) 32
9.2 Instruments Distribution Share (2006-2007)
34
9.3 Instruments Company Share (2006-2007) 35
10 Immunochemistry
Test Reagents in India 36
10.1 Immunochemistry Test Reagents Revenues by
Segment (2000-2012) 36
10.1.1 Disease Specific Test Reagents Revenues by
Sub-Segment (2000-2012) 38
10.1.2 Hormone Related Testing Reagents
Revenues by Sub-Segment (2000-2012) 40
10.1.3 Immunohistochemistry Test
Reagents Revenues by Sub-Segment (2000-2012) 42
10.2 Immunochemistry Test
Reagents Distribution Share (2006-2007) 44
10.3 Immunochemistry Test
Reagents Company Share (2006-2007) 45
11 Clinical Biochemistry Test
Reagents in India 46
11.1 Clinical Biochemistry Test Reagents Revenues
(2000-2012) 46
11.2 Clinical Biochemistry Test Reagents Distribution Share
(2006-2007) 48
11.3 Clinical Biochemistry Test Reagents Company Share
(2006-2007) 49
12 Haematology & Histopathology Test Reagents in India
50
12.1 Haematology & Histopathology Test Reagents Revenues by Segment
(2000-2012) 50
12.1.1 Haematology Test Reagents Revenues by Sub-Segment
(2000-2012) 52
12.1.2 Histopathology Reagents Revenues by Sub-Segment
(2000-2012) 54
12.2 Haematology & Histopathology Test Reagents
Distribution Share (2006-2007) 56
12.3 Haematology & Histopathology Test
Reagents Company Share (2006-2007) 57
13 Rapid Test Reagents in India
58
13.1 Rapid Tests Revenues by Segment (2000-2012) 58
13.2 Rapid
Tests Distribution Share (2006-2007) 60
13.3 Rapid Tests Company Share
(2006-2007) 61
14 Infectious Immunology Test Reagents in India 62
14.1
Infectious Immunology Test Reagents Revenues by Segment (2000-2012) 62
14.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 64
14.3 Infectious Immunology Test Reagents Company Share (2006-2007) 65
15
Microbiology Test Reagents in India 66
15.1 Microbiology Test Reagents
Revenues (2000-2012) 66
15.2 Microbiology Test Reagents Distribution Share
(2006-2007) 68
15.3 Microbiology Test Reagents Company Share (2006-2007)
69
16 Abbott Laboratories Company Profile 70
16.1 Company Overview
70
16.2 Value Chain Analysis 70
16.2.1 Manufacturing 71
16.2.2
Product Development 71
16.2.3 Sales and Marketing 72
17 Beckman
Coulter, Inc. Company Profile 73
17.1 Company Overview 73
17.2 Value
Chain Analysis 73
17.2.1 Manufacturing 74
17.2.2 Product Development
74
17.2.3 Sales and Marketing 74
17.3 Beckman Coulter, Inc. Pipeline
Products 75
17.3.1 Beckman Coulter, Inc. Pipeline Products by Equipment
Type 75
17.3.2 Beckman Coulter, Inc. Pipeline Products by Development
Stage 76
17.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area
77
17.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary 77
18 bioMerieux S.A. Company Profile 78
18.1 Company Overview 78
18.2
Value Chain Analysis 78
18.2.1 Manufacturing 79
18.2.2 Product
Development 79
18.2.3 Sales and Marketing 80
19 Siemens Medical
Solutions 81
19.1 Company Overview 81
19.1.1 Industry Outlook --
Diagnostic Imaging 81
19.2 Value Chain Analysis 82
19.2.1
Manufacturing 82
19.2.2 Product Development 83
19.2.3 Sales and
Marketing 83
20 Roche Diagnostics Limited Company Review 84
20.1
Company Overview 84
20.2 Roche Diagnostics Limited Pipeline Products
84
20.2.1 Roche Diagnostics Limited Pipeline Products by Equipment Type
84
20.2.2 Roche Diagnostics Limited Pipeline Products by Development Stage
86
20.2.3 Roche Diagnostics Limited Pipeline Products by Therapy Area
87
20.2.4 Roche Diagnostics Limited Pipeline Products by Clinical Trials
87
20.2.5 Roche Diagnostics Limited Pipeline Products by News Summary
88
21 J.Mitra & Co. Ltd. Company Review 89
21.1 Company Overview
89
22 Span Diagnostics Limited Company Review 90
22.1 Company Overview
90
23 Ortho-Clinical Diagnostics Inc. Company Review 91
23.1 Company
Overview 91
24 Gen-Probe Incorporated Company Profile 92
24.1 Company
Overview 92
24.2 Value Chain Analysis 92
24.2.1 Manufacturing 93
24.2.2 Product Development 93
24.2.3 Sales and Marketing 94
24.3
Gen-Probe Incorporated Pipeline Products 94
24.3.1 Gen-Probe Incorporated
Pipeline Products by Equipment Type 94
24.3.2 Gen-Probe Incorporated
Pipeline Products by Development Stage 96
24.3.3 Gen-Probe Incorporated
Pipeline Products by Therapy Area 97
24.3.4 Gen-Probe Incorporated
Pipeline Products by Clinical Trials 97
24.3.5 Gen-Probe Incorporated
Pipeline Products by News Summary 98
25 Becton, Dickinson and Company
Profile 99
25.1 Company Overview 99
25.2 Value Chain Analysis 99
25.2.1 Manufacturing 100
25.2.2 Product Development 100
25.2.3 Sales
and Marketing 100
26 Transasia Bio-Medicals Ltd. Company Profile 101
26.1 Company Overview 101
27 Accurex Biomedical Pvt. Ltd. Company Review
102
27.1 Company Overview 102
28 Bhat Bio-tech India (P)Ltd Company
Review 103
28.1 Company Overview 103
29 ATNT Laboratories Company
Review 104
29.1 Company Overview 104
30 Embee Diagnostics Company
Review 105
30.1 Company Overview 105
31 ST Corporation Company Review
106
31.1 Company Overview 106
32 Financial Deals Landscape 107
32.1 Merger 107
32.1.1 Canere Actives & Fine Chemicals Merges With
Nicholas Piramal India 107
32.1.2 DxTech Enters Into Partnership With
Nicholas Piramal India 108
32.1.3 Transasia Bio-Medicals Signs Agreement
With Grifols 110
33 Appendix 112
33.1 Global Markets Direct Research
Methodology 112
33.2 Coverage 113
33.3 Secondary Research 113
33.4
Primary Research 114
33.5 Models 114
33.6 Forecasts 115
33.7
Expert Panels 115
33.8 Currency Conversion 116
33.9 Contact Us 117
33.10 Disclaimer 117
1.1 List of Tables
Table 1: Healthcare
Infrastructure (2007) 22
Table 2: In Vitro Diagnostics, India, Category
Revenues ($ mn), 2000-2012 29
Table 3: In Vitro Diagnostics, India,
Category Revenues ($ mn), Historic, 2000-2007 30
Table 4: In Vitro
Diagnostics, India, Category Revenues ($ mn), Forecast, 2007-2012 31
Table
5: Instruments, India, Revenue ($ mn), Historic, 2000-2007 32
Table 6:
Instruments, India, Revenue ($ mn), Forecast, 2007-2012 33
Table 7:
Instruments, India, Distribution Share by Revenue ($ mn), 2006-2007 34
Table 8: Instruments, India, Company Share by Revenue ($ mn), 2006-2007 35
Table 9: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment,
Historic, 2000-2007 36
Table 10: Immunochemistry Test Reagents, India,
Revenue ($ mn) by Segment, Forecast, 2007-2012 37
Table 11: Disease
Specific Test Reagents, India, Revenue ($ mn) by Sub-segment, Historic,
2000-2007 38
Table 12: Disease Specific Test Reagents, India, Revenue ($
mn) by Sub-segment, Forecast, 2007-2012 39
Table 13: Hormone Related
Testing Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007
40
Table 14: Hormone Related Testing Reagents, India, Revenue ($ mn) by
Sub-segment, Forecast, 2007-2012 41
Table 15: Immunohistochemistry Test
Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 42
Table 16: Immunohistochemistry Test Reagents, India, Revenue ($ mn) by
Sub-segment, Forecast, 2007-2012 43
Table 17: Immunochemistry Test
Reagents, India, Distribution Share by Revenue ($ mn), 2006-2007 44
Table
18: Immunochemistry Test Reagents, India, Company Share by Revenue ($ mn),
2006-2007 45
Table 19: Clinical Biochemistry Test Reagents, India, Revenue
($ mn), Historic, 2000-2007 46
Table 20: Clinical Biochemistry Test
Reagents, India, Revenue ($ mn), Forecast, 2007-2012 47
Table 21: Clinical
Biochemistry Test Reagents, India, Distribution Share by Revenue ($ mn),
2006-2007 48
Table 22: Clinical Biochemistry Test Reagents, India, Company
Share by Revenue ($ mn), 2006-2007 49
Table 23: Haematology &
Histopathology Test Reagents, India, Revenue ($ mn) by Segment, Historic,
2000-2007 50
Table 24: Haematology & Histopathology Test Reagents, India,
Revenue ($ mn) by Segment, Forecast, 2007-2012 51
Table 25: Haematology
Test Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007
52
Table 26: Haematology Test Reagents, India, Revenue ($ mn) by
Sub-segment, Forecast, 2007-2012 53
Table 27: Histopathology Reagents,
India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 54
Table 28:
Histopathology Reagents, India, Revenue ($ mn) by Sub-segment, Forecast,
2007-2012 55
Table 29: Haematology & Histopathology Test Reagents, India,
Distribution Share by Revenue ($ mn), 2006-2007 56
Table 30: Haematology &
Histopathology Test Reagents, India, Company Share by Revenue ($ mn),
2006-2007 57
Table 31: Rapid Tests, India, Revenue ($ mn) by Segment,
Historic, 2000-2007 58
Table 32: Rapid Tests, India, Revenue ($ mn) by
Segment, Forecast, 2007-2012 59
Table 33: Rapid Tests, India, Distribution
Share by Revenue ($ mn), 2006-2007 60
Table 34: Rapid Tests, India,
Company Share by Revenue ($ mn), 2006-2007 61
Table 35: Infectious
Immunology Test Reagents, India, Revenue ($ mn) by Segment, Historic,
2000-2007 62
Table 36: Infectious Immunology Test Reagents, India, Revenue
($ mn) by Segment, Forecast, 2007-2012 63
Table 37: Infectious Immunology
Test Reagents, India, Distribution Share by Revenue ($ mn), 2006-2007 64
Table 38: Infectious Immunology Test Reagents, India, Company Share by Revenue
($ mn), 2006-2007 65
Table 39: Microbiology Test Reagents, India, Revenue
($ mn), Historic, 2000-2007 66
Table 40: Microbiology Test Reagents,
India, Revenue ($ mn), Forecast, 2007-2012 67
Table 41: Microbiology Test
Reagents, India, Distribution Share by Revenue ($ mn), 2006-2007 68
Table
42: Microbiology Test Reagents, India, Company Share by Revenue ($ mn),
2006-2007 69
Table 43: Beckman Coulter, Inc. Pipeline Products by
Equipment Type 75
Table 44: Beckman Coulter, Inc. Pipeline Products
By Development Stage 76
Table 45: Beckman Coulter, Inc. Pipeline
Products By Therapy Area 77
Table 46: Beckman Coulter, Inc. Pipeline
Products By News Summaries 77
Table 47: Roche Diagnostics Limited
Pipeline Products by Equipment Type 85
Table 48: Roche Diagnostics
Limited Pipeline Products By Development Stage 86
Table 49: Roche
Diagnostics Limited Pipeline Products By Therapy Area 87
Table 50:
Roche Diagnostics Limited Pipeline Products By Clinical Trials 87
Table
51: Roche Diagnostics Limited Pipeline Products By News Summaries 88
Table 52: Gen-Probe Incorporated Pipeline Products by Equipment Type
95
Table 53: Gen-Probe Incorporated Pipeline Products By Development
Stage 96
Table 54: Gen-Probe Incorporated Pipeline Products By
Therapy Area 97
Table 55: Gen-Probe Incorporated Pipeline Products By
Clinical Trials 97
Table 56: Gen-Probe Incorporated Pipeline Products
By News Summaries 98
Table 57: Currency Conversion from USD to Local
Currency at 2007 Constant Rate 116
1.2 List of Figures
Figure 1:
Total Healthcare Expenditure in India, 2000-2006 20
Figure 2: Healthcare
Expenditure in India by Source, 2006 21
Figure 3: Proposed Medical
Equipment Classification in India, 2005 26
Figure 4: In Vitro Diagnostics,
India, Category Revenues ($ mn), 2000-2012 29
Figure 5: In Vitro
Diagnostics, India, Category Revenues ($ mn), Historic, 2000-2007 30
Figure 6: In Vitro Diagnostics, India, Category Revenues ($ mn), Forecast,
2007-2012 31
Figure 7: Instruments, India, Revenue ($ mn), Historic,
2000-2007 32
Figure 8: Instruments, India, Revenue ($ mn), Forecast,
2007-2012 33
Figure 9: Instruments, India, Company Share (%), 2007 35
Figure 10: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment,
Historic, 2000-2007 36
Figure 11: Immunochemistry Test Reagents, India,
Revenue ($ mn) by Segment, Forecast, 2007-2012 37
Figure 12: Disease
Specific Test Reagents, India, Revenue ($ mn) by Sub-segment, Historic,
2000-2007 38
Figure 13: Disease Specific Test Reagents, India, Revenue ($
mn) by Sub-segment, Forecast, 2007-2012 39
Figure 14: Hormone Related
Testing Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007
40
Figure 15: Hormone Related Testing Reagents, India, Revenue ($ mn) by
Sub-segment, Forecast, 2007-2012 41
Figure 16: Immunohistochemistry Test
Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 42
Figure 17: Immunohistochemistry Test Reagents, India, Revenue ($ mn) by
Sub-segment, Forecast, 2007-2012 43
Figure 18: Immunochemistry Test
Reagents, India, Company Share (%), 2007 45
Figure 19: Clinical
Biochemistry Test Reagents, India, Revenue ($ mn), Historic, 2000-2007 46
Figure 20: Clinical Biochemistry Test Reagents, India, Revenue ($ mn),
Forecast, 2007-2012 47
Figure 21: Clinical Biochemistry Test Reagents,
India, Company Share (%), 2007 49
Figure 22: Haematology & Histopathology
Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2007 50
Figure 23: Haematology & Histopathology Test Reagents, India, Revenue ($ mn)
by Segment, Forecast, 2007-2012 51
Figure 24: Haematology Test Reagents,
India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 52
Figure 25:
Haematology Test Reagents, India, Revenue ($ mn) by Sub-segment, Forecast,
2007-2012 53
Figure 26: Histopathology Reagents, India, Revenue ($ mn) by
Sub-segment, Historic, 2000-2007 54
Figure 27: Histopathology Reagents,
India, Revenue ($ mn) by Sub-segment, Forecast, 2007-2012 55
Figure 28:
Haematology & Histopathology Test Reagents, India, Company Share (%), 2007
57
Figure 29: Rapid Tests, India, Revenue ($ mn) by Segment, Historic,
2000-2007 58
Figure 30: Rapid Tests, India, Revenue ($ mn) by Segment,
Forecast, 2007-2012 59
Figure 31: Rapid Tests, India, Company Share (%),
2006 61
Figure 32: Infectious Immunology Test Reagents, India, Revenue ($
mn) by Segment, Historic, 2000-2007 62
Figure 33: Infectious Immunology
Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2007-2012 63
Figure 34: Infectious Immunology Test Reagents, India, Company Share (%), 2007
65
Figure 35: Microbiology Test Reagents, India, Revenue ($ mn), Historic,
2000-2007 66
Figure 36: Microbiology Test Reagents, India, Revenue ($ mn),
Forecast, 2007-2012 67
Figure 37: Microbiology Test Reagents, India,
Company Share (%), 2007 69
Figure 38: Abbott Laboratories, Value
Chain Analysis 70
Figure 39: Beckman Coulter, Inc., Value Chain Analysis
73
Figure 40: bioMerieux S.A., Value Chain Analysis 78
Figure 41:
Siemens Medical Solutions, Value Chain Analysis 82
Figure 42: Roche
Diagnostics Limited Pipeline Products By Equipment Type 84
Figure 43:
Roche Diagnostics Limited Pipeline Products By Equipment Type 85
Figure
44: Roche Diagnostics Limited Pipeline Products By Development Stage
86
Figure 45: Roche Diagnostics Limited Pipeline Products By News
Summary 88
Figure 46: Gen-Probe Incorporated, Value Chain Analysis 92
Figure 47: Gen-Probe Incorporated Pipeline Products By Equipment Type
94
Figure 48: Gen-Probe Incorporated Pipeline Products By Equipment
Type 95
Figure 49: Gen-Probe Incorporated Pipeline Products By
Development Stage 96
Figure 50: Gen-Probe Incorporated Pipeline
Products By News Summary 98
Figure 51: Becton, Dickinson and Company,
Value Chain Analysis 99
Figure 52: Global Markets Direct Methodology
112
